Stock MDC MEDICA S.P.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Medica S.p.A.

Equities

MDC

IT0005460149

Biotechnology & Medical Research

Market Closed - Borsa Italiana
Other stock markets
 11:44:59 2024-05-31 am EDT 		5-day change 1st Jan Change
26.6 EUR +0.76% Intraday chart for Medica S.p.A. +0.76% +71.61%
Apr. 29 Donaldson Agrees to Acquire 49% Stake in Medica MT
Apr. 26 Response Plus Unit Closes Prometheus Medical Acquisition MT

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 170 110.2 65.46 112.3 - -
Enterprise Value (EV) 1 159.2 114.6 65.46 118.3 107.5 94.77
P/E ratio 34.1 x 25.3 x - 16.5 x 12 x 9.55 x
Yield - - - - - -
Capitalization / Revenue 3.88 x 2.17 x 0.82 x 1.21 x 1.11 x 1.02 x
EV / Revenue 3.63 x 2.25 x 0.82 x 1.27 x 1.06 x 0.86 x
EV / EBITDA 16.1 x 10.3 x 5.59 x 6.65 x 5.18 x 4.02 x
EV / FCF -35.7 x -7.37 x - 15.3 x 10.1 x 7.4 x
FCF Yield -2.8% -13.6% - 6.55% 9.95% 13.5%
Price to Book 3.78 x 2.24 x - 1.87 x 1.62 x 1.38 x
Nbr of stocks (in thousands) 4,223 4,223 4,223 4,223 - -
Reference price 2 40.25 26.10 15.50 26.60 26.60 26.60
Announcement Date 3/30/22 3/30/23 3/25/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 44.06 43.8 50.86 79.98 93.11 101.5 110.4
EBITDA 1 - 9.897 11.17 11.72 17.79 20.74 23.6
EBIT 1 - 5.824 5.264 4.56 9.625 12.54 15.43
Operating Margin - 13.3% 10.35% 5.7% 10.34% 12.35% 13.98%
Earnings before Tax (EBT) 1 - 5.617 4.811 3.41 8.58 11.75 14.82
Net income 1 3.772 4.973 4.35 2.967 6.825 9.335 11.79
Net margin 8.56% 11.35% 8.55% 3.71% 7.33% 9.2% 10.68%
EPS 2 - 1.180 1.030 - 1.615 2.210 2.785
Free Cash Flow 1 - -4.459 -15.55 - 7.75 10.7 12.8
FCF margin - -10.18% -30.58% - 8.32% 10.54% 11.59%
FCF Conversion (EBITDA) - - - - 43.56% 51.58% 54.24%
FCF Conversion (Net income) - - - - 113.55% 114.62% 108.57%
Dividend per Share - - - - - - -
Announcement Date 12/27/21 3/30/22 3/30/23 3/25/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 S1 2022 S2 2023 S2
Net sales 20.42 30.44 -
EBITDA 1 - 7.415 8
EBIT 1 - 3.568 4.354
Operating Margin - 11.72% -
Earnings before Tax (EBT) 1 - 3.183 3.794
Net income 1 1.27 3.08 2.784
Net margin 6.22% 10.12% -
EPS - - -
Dividend per Share - - -
Announcement Date 9/28/22 3/30/23 3/25/24
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - 4.34 - 5.92 - -
Net Cash position 1 - 10.8 - - - 4.79 17.6
Leverage (Debt/EBITDA) - - 0.3883 x - 0.3325 x - -
Free Cash Flow 1 - -4.46 -15.6 - 7.75 10.7 12.8
ROE (net income / shareholders' equity) - 14.9% 8.94% - 11.9% 14.1% 15.3%
ROA (Net income/ Total Assets) - 8.55% 5.41% - 10.9% 13.1% 14.5%
Assets 1 - 58.16 80.36 - 62.61 71.26 81.31
Book Value Per Share 2 - 10.70 11.70 - 14.20 16.50 19.20
Cash Flow per Share 2 - 1.010 - - 4.460 4.190 4.250
Capex 1 - 8.73 6.93 - 7 4.3 4.5
Capex / Sales - 19.94% 13.63% - 7.52% 4.24% 4.08%
Announcement Date 12/27/21 3/30/22 3/30/23 3/25/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Medica S.p.A.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
26.6 EUR
Average target price
31.4 EUR
Spread / Average Target
+18.05%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MEDICA S.P.A. Stock Medica S.p.A.
+71.61% 122M
MODERNA, INC. Stock Moderna, Inc.
+43.36% 54.64B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-5.31% 39.92B
LONZA GROUP AG Stock Lonza Group AG
+37.52% 38.82B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+14.75% 26.86B
CELLTRION, INC. Stock Celltrion, Inc.
-12.56% 26.22B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-22.45% 18.78B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+25.12% 12.21B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.04% 12.16B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.04% 11.94B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. MDC Stock
  4. Financials Medica S.p.A.